Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Board of Directors of Sollers recommended that dividends be paid for 2024

4/24/25 SVAV

RusHydro in Q1 reduced energy generation by 5.7%

4/24/25 HYDR

Sollers launched in Yelabuga the production of SF1

4/24/25 SVAV

Yandex enters a new segment of the advertising market

4/24/25 YDEX

M.Video-Eldorado replaced its CFO

4/24/25 MVID

Ozone Pharmaceuticals expects revenue growth in 2025 by 25%

4/24/25 OZPH

Chizhik has significantly expanded its delivery geography

4/24/25 FIVE

X5 will launch first distribution center in the Far East

4/24/25 FIVE

VK's revenue in Q1 grew by 16%

4/24/25 VKCO

MMK reported for 3 months of 2025 by IFRS

4/24/25 MAGN